Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Chugai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.

Takeda offloads select portfolio to Acino ahead of Shire takeover

Takeda offloads select portfolio to Acino ahead of Shire takeover However, Takeda maintained that Shire will help it grow outside Japan, and increase the company’s pipeline in the process.

Gilead promotes Andrew Dickinson to CFO, increased M&A expected

Gilead promotes Andrew Dickinson to CFO, increased M&A expected The drug is already under review in Europe and Japan, with plans to file in the US soon.

Gilead poaches Genentech-exec Merdad Parsey for its new CMO

Gilead poaches Genentech-exec Merdad Parsey for its new CMO Company also files potential blockbuster filgotinib in Japan. As new CEO Daniel O’Day continues to overhaul Gilead’s top positions, Roche subsidiary Genentech’s Merdad Parsey has been appointed as ... The Galapagos-partnered drug is due to be

Sarepta rival NS Pharma files Duchenne drug with FDA

Sarepta rival NS Pharma files Duchenne drug with FDA NS Pharma’s Viltolarsen was granted a Rare Paediatric Disease Designation, Orphan Drug Designation and Fast Track Designation in the US and ‘SAKIGAKE designation’ and ‘Orphan drug designation’ in Japan, where

AstraZeneca sells Losec rights as part of refocus strategy

AstraZeneca sells Losec rights as part of refocus strategy This excludes the rights in China, Japan, the US and Mexico, AZ has said. ... The therapy received approval in Japan in June, and is also under regulatory review in China and in the EU.

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics